Key facts
- Orca Capital AG filed SCHEDULE 13G/A for 60 Degrees Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SXTP).
- Disclosed ownership: 4.9%.
- Date of event: 15 Jul 2025.
Orca Capital AG - 15 Jul 2025 SCHEDULE 13G/A Report for 60 Degrees Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SXTP)
- Filing Manager
- Orca Capital AG
- Reporting Manager
- Orca Capital AG
- Symbol
- SXTP
- Shares outstanding
- 3,392,429 shares
- Disclosed Ownership
- 166,229 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Jul 2025, 16:59:42 UTC
- Date of event
- 15 Jul 2025
- SEC
- View on sec.gov
Key filing fact
Orca Capital AG disclosed 4.9% ownership in 60 Degrees Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SXTP) on 15 Jul 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Jul 2025, 16:59.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Orca Capital AG | 4.9% | 166,229 | 166,229 | 0 | /s/ Thomas Konig | Thomas Konig/Director |
CIK / CUSIP context first